Covered recipient · General Payments record
RYYAN HYDER
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2021–2023
$472.52
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $85.91 | 5 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $39.65 | 2 |
| Aurinia Pharma U.S., Inc. | $19.88 | 1 |
| Mallinckrodt Hospital Products Inc. | $19.12 | 1 |
| Retrophin, Inc. | $7.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (5)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $20.21 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015230531 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.44 | 07/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015858546 | CMS |
| Aurinia Pharma U.S., Inc. | $19.88 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057735865 | CMS |
| Mallinckrodt Hospital Products Inc. | $19.12 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1042842485 | CMS |
| Travere Therapeutics, Inc. | $7.26 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059557443 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.